Skip to main content
. 2014 Feb 5;99(4):926–933. doi: 10.3945/ajcn.113.067488

TABLE 1.

Baseline characteristics of the WHI Observational Study participants by quintile of total magnesium intake1

<206.5 mg 206.5–270.2 mg 270.3–333.7 mg 333.8–422.4 mg ≥422.5 mg P
Age [n (Ann %)] <0.001
 50–59 y 4923 (33.9) 4825 (32.7) 4848 (32.6) 4737 (31.6) 4987 (33.5)
 60–69 y 6191 (42.6) 6400 (43.3) 6441 (43.4) 6656 (44.4) 6592 (44.3)
 70–79 y 3426 (23.6) 3544 (24.0) 3560 (24.0) 3607 (24.0) 3294 (22.1)
Race-ethnicity [n (Ann %)] <0.001
 White 10,877 (74.8) 12,419 (84.1) 12,999 (87.5) 13,464 (89.8) 13,326 (89.6)
 Black 1888 (13.0) 1074 (7.3) 802 (5.4) 668 (4.5) 601 (4.0)
 Hispanic 821 (5.6) 577 (3.9) 425 (2.9) 360 (2.4) 344 (2.3)
 American Indian 82 (0.6) 61 (0.4) 47 (0.3) 34 (0.2) 49 (0.3)
 Asian/Pacific Islander 630 (4.3) 447 (3.0) 410 (2.8) 319 (2.1) 356 (2.4)
 Unknown 242 (1.7) 191 (1.3) 166 (1.1) 155 (1.0) 197 (1.3)
Parental history of fracture [n (Ann %)] 5353 (36.8) 5772 (39.1) 5890 (39.7) 6186 (41.2) 6184 (41.6) <0.001
Fracture at ≥55 y of age [n (Ann %)] 1919 (13.2) 2170 (14.7) 2156 (14.5) 2223 (14.8) 2299 (15.5) <0.001
BMI [n (Ann %)] <0.001
 <25 kg/m2 5545 (38.1) 6102 (41.3) 6268 (42.2) 6359 (42.4) 6483 (43.6)
 ≥25 kg/m2 8995 (61.9) 8667 (58.7) 8581 (57.8) 8641 (57.6) 8390 (56.4)
History of MI or angina [n (Ann %)] 1076 (7.4) 1018 (6.9) 888 (6.0) 943 (6.3) 928 (6.2) <0.001
Treated diabetes [n (Ann %)] 699 (4.8) 599 (4.1) 528 (3.6) 542 (3.6) 486 (3.3) <0.001
Self-reported health [n (Ann %)] <0.001
 Excellent 2260 (15.5) 2719 (18.4) 2875 (19.4) 2906 (19.4) 3017 (20.3)
 Very good 5537 (38.1) 5975 (40.5) 6294 (42.4) 6482 (43.2) 6385 (42.9)
 Good 4993 (34.3) 4765 (32.3) 4504 (30.3) 4475 (29.8) 4370 (29.4)
 Fair/poor 1750 (12.0) 1310 (8.9) 1176 (7.9) 1137 (7.6) 1101 (7.4)
HT use [n (Ann %)] <0.001
 Never/past user 9704 (66.7) 9494 (64.3) 9474 (63.8) 9522 (63.5) 9403 (63.2)
 <5 y 1748 (12.0) 1925 (13.0) 1945 (13.1) 1897 (12.6) 1974 (13.3)
 5 to <10 y 1262 (8.7) 1359 (9.2) 1471 (9.9) 1533 (10.2) 1516 (10.2)
 10 to <15 y 776 (5.3) 885 (6.0) 880 (5.9) 967 (6.4) 929 (6.2)
 ≥15 y 1050 (7.2) 1106 (7.5) 1079 (7.3) 1081 (7.2) 1051 (7.1)
Thiazide use [n (Ann %)] <0.001
 Nonuser 13,689 (94.1) 13,983 (94.7) 14,059 (94.7) 14,249 (95.0) 14,185 (95.4)
 <10 y 616 (4.2) 566 (3.8) 532 (3.6) 514 (3.4) 480 (3.2)
 ≥10 y 235 (1.6) 220 (1.5) 258 (1.7) 236 (1.6) 208 (1.4)
Current corticosteroid use [n (Ann %)] 208 (1.4) 207 (1.4) 184 (1.2) 187 (1.2) 181 (1.2) 0.380
Alcohol intake [n (Ann %)] <0.001
 Nondrinker 2088 (14.4) 1649 (11.2) 1556 (10.5) 1406 (9.4) 1350 (9.1)
 Past drinker 3026 (20.8) 2682 (18.2) 2503 (16.9) 2481 (16.5) 2722 (18.3)
 <1 drink/mo 1879 (12.9) 1825 (12.4) 1667 (11.2) 1566 (10.4) 1626 (10.9)
 <1 drink/wk 2922 (20.1) 2920 (19.8) 3034 (20.4) 3023 (20.2) 2999 (20.2)
 1 to <7 drinks/wk 3231 (22.2) 3872 (26.2) 4040 (27.2) 4269 (28.5) 4128 (27.8)
 ≥7 drinks/wk 1394 (9.6) 1821 (12.3) 2049 (13.8) 2255 (15.0) 2048 (13.8)
Smoking status [n (Ann %)] <0.001
 Never 7449 (51.2) 7571 (51.3) 7570 (51.0) 7649 (51.0) 7617 (51.2)
 Past 5758 (39.6) 6211 (42.1) 6477 (43.6) 6631 (44.2) 6719 (45.2)
 Current 1333 (9.2) 987 (6.7) 802 (5.4) 720 (4.8) 537 (3.6)
Total daily calcium intake [n (Ann %)]2 <0.001
 <600 mg 8233 (56.6) 3331 (22.6) 1168 (7.9) 323 (2.2) 125 (0.8)
 600–1500 mg 5283 (36.3) 9325 (63.1) 10,029 (67.5) 8814 (58.8) 4879 (32.8)
 >1500 mg 1024 (7.0) 2113 (14.3) 3652 (24.6) 5863 (39.1) 9869 (66.4)
Total daily vitamin D intake [n (Ann %)]2 <0.001
 <200 IU 11,303 (77.7) 7205 (48.8) 3898 (26.3) 1974 (13.2) 1460 (9.8)
 200–500 IU 2516 (17.3) 5253 (35.6) 5804 (39.1) 4778 (31.9) 3435 (23.1)
 >500 IU 721 (5.0) 2311 (15.6) 5147 (34.7) 8248 (55.0) 9978 (67.1)
Physical activity [n (Ann %)] <0.001
 Inactive 2863 (19.7) 2146 (14.5) 1795 (12.1) 1558 (10.4) 1385 (9.3)
 <5 METs/wk 3460 (23.8) 2956 (20.0) 2759 (18.6) 2573 (17.2) 2191 (14.7)
 5–12 METs/wk 3349 (23.0) 3667 (24.8) 3592 (24.2) 3609 (24.1) 3339 (22.5)
 >12 METs/wk 4792 (33.0) 5918 (40.1) 6602 (44.5) 7155 (47.7) 7860 (52.8)
Time spent walking [n (Ann %)] <0.001
 0 min/wk 7250 (49.9) 6289 (42.6) 5628 (37.9) 5385 (35.9) 4951 (33.3)
 >0–150 min/wk 5423 (37.3) 6237 (42.2) 6702 (45.1) 6989 (46.6) 6905 (46.4)
 >150 min/wk 1867 (12.8) 2243 (15.2) 2519 (17.0) 2626 (17.5) 3017 (20.3)
Family income [n (Ann %)] <0.001
 <$10,000 818 (5.6) 538 (3.6) 421 (2.8) 382 (2.5) 422 (2.8)
 $10,000–$19,999 1866 (12.8) 1515 (10.3) 1356 (9.1) 1357 (9.0) 1312 (8.8)
 $20,000–$34,999 3316 (22.8) 3234 (21.9) 3128 (21.1) 3155 (21.0) 3045 (20.5)
 $35,000–$49,999 2606 (17.9) 2762 (18.7) 2857 (19.2) 2900 (19.3) 2915 (19.6)
 $50,000–$74,999 2435 (16.7) 2760 (18.7) 2970 (20.0) 2946 (19.6) 3098 (20.8)
 ≥$75,000 2354 (16.2) 2906 (19.7) 3112 (21.0) 3166 (21.1) 3142 (21.1)
US region [n (Ann %)] <0.001
 Northeast 3381 (23.3) 3573 (24.2) 3597 (24.2) 3574 (23.8) 3290 (22.1)
 South 4298 (29.6) 3816 (25.8) 3700 (24.9) 3559 (23.7) 3257 (21.9)
 Midwest 2877 (19.8) 3269 (22.1) 3444 (23.2) 3776 (25.2) 3376 (22.7)
 West 3984 (27.4) 4111 (27.8) 4108 (27.7) 4091 (27.3) 4950 (33.3)
1

All variables were assessed at the baseline screening visit. Magnesium values include the combined intake from food and supplements (range: 0.38–9274 mg/d; 99th percentile: 958 mg/d). P values were based on significant differences between all quintiles. Ann, annual; HT, hormone therapy; MET, metabolic equivalent task; MI, myocardial infarction; WHI, Women's Health Initiative.

2

Calcium and vitamin D values include the combined intake from food and supplements.